scholarly journals Effect of Narrow Band Ultraviolet B Therapy versus Methotrexate on Serum Levels of Interleukin-17 and Interleukin-23 in Egyptian Patients with Severe Psoriasis

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Tarek Mahmoud Elghandour ◽  
Sahar El Sayed Youssef ◽  
Dalia Gamal Aly ◽  
Mohamed Said Abd Elhameed ◽  
Mehrevan Mostafa Abdel Moneim
Keyword(s):  
Narrow Band ◽  
Serum Levels ◽  
Severe Psoriasis ◽  
Ultraviolet B ◽  
Interleukin 17 ◽  
Egyptian Patients ◽  
Interleukin 23

scholarly journals Effect of Narrow Band Ultraviolet B Therapy on Serum Levels of Interleukin22 in Egyptian Patients with Psoriasis

2015 ◽  
Vol 8 (1) ◽  
pp. 1-7
Author(s):  
Moheiddin Alghobary ◽  
Manar Sallam ◽  
Sherin Ezz-Elrega ◽  
Hanaa Morkos Abdel-Mass ◽  
Heba Mosaad
Keyword(s):  
Narrow Band ◽  
Serum Levels ◽  
Ultraviolet B ◽  
Egyptian Patients

Satisfaction and Awareness of Systemic Psoriasis Treatments: A National Survey Comparing Biologic and Nonbiologic Users

2019 ◽  
Vol 23 (2) ◽  
pp. 148-156 ◽  
Author(s):  
Arvin Ighani ◽  
Ashley M. Yu ◽  
Vijay K. Sandhu ◽  
Benjamin Barankin ◽  
Morris F. Manolson
Keyword(s):  
Treatment Satisfaction ◽  
Treatment Options ◽  
Primary Treatment ◽  
Biologic Agents ◽  
Severe Psoriasis ◽  
Interleukin 17 ◽  
Primary Treatment Modality ◽  
Interleukin 23 ◽  
The Impact ◽  
Systemic Agents

Background: There is ongoing development of new therapies for psoriasis, including biologic and systemic agents such as interleukin-17, interleukin-23, and phosphodiesterase-4 inhibitors. The development of these agents has changed the landscape of psoriasis treatment options. Objective: The objective of this study was to characterize the impact of newer biologic and systemic agents approved by June 2016 on patient outcomes. We sought to evaluate and compare biologic users and nonbiologic systemic users with respect to their treatment awareness and satisfaction. Methods: We conducted a national Canadian survey from July to September 2016 on adult patients with moderate-to-severe psoriasis using biologic agents or nonbiologic systemic agents as their current primary treatment modality. Patients were asked to evaluate their overall satisfaction with their treatment agent and their awareness of other treatment options. Responses from biologic and nonbiologic systemic users were compared. Results: Overall, 343 participants were included (biologic users: n = 218; nonbiologic users: n = 125). Treatment satisfaction: Biologic users had a higher overall satisfaction score than nonbiologic users ( P < .001). Among nonbiologic agents, apremilast (62%) was associated with the highest satisfaction proportion. Among biologic agents, ustekinumab (77%) and adalimumab (72%) were associated with the highest proportions of satisfaction. With respect to treatment awareness, 30% of nonbiologic patients did not have enough information to form an opinion about biologics. Conclusions: This study demonstrates the greater treatment satisfaction of biologic users compared with nonbiologic users for moderate-to-severe psoriasis. Given that nearly one-third of nonbiologic users did not have enough information to form an opinion about biologic agents, physicians may consider counselling these patients on the use of biologic agents for psoriasis management.

Levels of Interleukin 17 , Interleukin 23 and Interleukin 27 in Rheumatoid Arthritis and Osteoarthritis in Egyptian Patients

2013 ◽  
Vol 42 (4) ◽  
pp. 629-642 ◽  
Author(s):  
Ashraf Ismail Mustafa Khalifa ◽  
Hanan Abd Elmawgood Atia ◽  
Sara Saad
Keyword(s):  
Rheumatoid Arthritis ◽  
Interleukin 17 ◽  
Interleukin 27 ◽  
Egyptian Patients ◽  
Interleukin 23

Decreased serum levels of interleukin‐17, interleukin‐23, TGF ‐β in pemphigus vulgaris patients, and their association with disease phase

2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Zeinab Gholibeigian ◽  
Maryam Izad ◽  
Maryam Daneshpazhooh ◽  
Hossein Mortazavi ◽  
Zahra Salehi ◽  
...  
Keyword(s):  
Pemphigus Vulgaris ◽  
Serum Levels ◽  
Interleukin 17 ◽  
Interleukin 23

Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation

2009 ◽  
Vol 15 (6) ◽  
pp. 629-633 ◽  
Author(s):  
Emilio Fábrega ◽  
Marcos López-Hoyos ◽  
David San Segundo ◽  
Fernando Casafont ◽  
Fernando Pons-Romero
Keyword(s):  
Liver Transplantation ◽  
Acute Rejection ◽  
Serum Levels ◽  
Interleukin 17 ◽  
Interleukin 23

Therapeutic implications of narrow band ultraviolet B on psoriasis severity and serum levels of acute phase reactants

2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Hesham A. Nada ◽  
Mohamed M. Elshabrawy ◽  
Doaa M. Aly ◽  
Mohammad Jafferany ◽  
Mohamed L. Elsaie
Keyword(s):  
Acute Phase ◽  
Narrow Band ◽  
Serum Levels ◽  
Ultraviolet B ◽  
Acute Phase Reactants ◽  
Therapeutic Implications ◽  
Psoriasis Severity
Sign in / Sign up

Export Citation Format

Share Document